Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy

Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy

In the recent past, we observed an increased risk of cancer in the population with human immunodeficiency virus (HIV) owing to the development of antiretroviral therapies that decreased mortality caused by HIV-specific infections. This particularly fragile population is frequently excluded from clin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lise Bertin, MD, Anthony Canellas, MD, Baptiste Abbar, MD, Marianne Veyri, Jean-Philippe Spano, MD, PhD, Jacques Cadranel, MD, PhD, Armelle Lavolé, MD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
HIV
Anti–PD-1
CD4+
Viral load
Lung cancer
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/ec6f4644ae4240f5bb7de65702a720dc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/ec6f4644ae4240f5bb7de65702a720dc

Ejemplares similares